Clark E A, Golub T R, Lander E S, Hynes R O
Howard Hughes Medical Institute, Centre for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA.
Nature. 2000 Aug 3;406(6795):532-5. doi: 10.1038/35020106.
The most damaging change during cancer progression is the switch from a locally growing tumour to a metastatic killer. This switch is believed to involve numerous alterations that allow tumour cells to complete the complex series of events needed for metastasis. Relatively few genes have been implicated in these events. Here we use an in vivo selection scheme to select highly metastatic melanoma cells. By analysing these cells on DNA arrays, we define a pattern of gene expression that correlates with progression to a metastatic phenotype. In particular, we show enhanced expression of several genes involved in extracellular matrix assembly and of a second set of genes that regulate, either directly or indirectly, the actin-based cytoskeleton. One of these, the small GTPase RhoC, enhances metastasis when overexpressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho or RhoC indicates that RhoC is important in tumour cell invasion. The genomic approach allows us to identify families of genes involved in a process, not just single genes, and can indicate which molecular and cellular events might be important in complex biological processes such as metastasis.
癌症进展过程中最具破坏性的变化是从局部生长的肿瘤转变为转移性杀手。据信这种转变涉及众多改变,使肿瘤细胞能够完成转移所需的一系列复杂事件。相对而言,仅有少数基因与这些事件有关。在此,我们采用一种体内筛选方案来选择高转移性黑色素瘤细胞。通过在DNA阵列上分析这些细胞,我们确定了一种与向转移表型进展相关的基因表达模式。特别是,我们发现参与细胞外基质组装的几个基因以及另一组直接或间接调节基于肌动蛋白的细胞骨架的基因表达增强。其中之一,小GTP酶RhoC,过表达时会增强转移,而显性负性Rho则抑制转移。对表达显性负性Rho或RhoC的细胞表型分析表明,RhoC在肿瘤细胞侵袭中很重要。这种基因组方法使我们能够识别参与某一过程的基因家族,而非仅仅单个基因,并可指出哪些分子和细胞事件在诸如转移等复杂生物学过程中可能很重要。